ent-Kaur-16-en-19-ol

ID: ALA512447

Chembl Id: CHEMBL512447

PubChem CID: 24883422

Max Phase: Preclinical

Molecular Formula: C20H32O

Molecular Weight: 288.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C[C@@]23CC[C@@H]4[C@](C)(CO)CCC[C@@]4(C)[C@@H]2CC[C@H]1C3

Standard InChI:  InChI=1S/C20H32O/c1-14-11-20-10-7-16-18(2,13-21)8-4-9-19(16,3)17(20)6-5-15(14)12-20/h15-17,21H,1,4-13H2,2-3H3/t15-,16+,17-,18-,19+,20+/m0/s1

Standard InChI Key:  TUJQVRFWMWRMIO-GNVSMLMZSA-N

Alternative Forms

  1. Parent:

    ALA512447

    ent-Kaurenol

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSD11B1 Tclin 11-beta-hydroxysteroid dehydrogenase 1 (5910 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSD11B2 Tchem 11-beta-hydroxysteroid dehydrogenase 2 (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hsd11b1 11-beta-hydroxysteroid dehydrogenase 1 (1542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hsd11b2 11-beta-hydroxysteroid dehydrogenase 2 (377 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.48Molecular Weight (Monoisotopic): 288.2453AlogP: 4.95#Rotatable Bonds: 1
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.34CX LogD: 4.34
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.68Np Likeness Score: 3.31

References

1. Batista R, Humberto JL, Chiari E, de Oliveira AB..  (2007)  Synthesis and trypanocidal activity of ent-kaurane glycosides.,  15  (1): [PMID:17055730] [10.1016/j.bmc.2006.09.048]
2. Wu YC, Hung YC, Chang FR, Cosentino M, Wang HK, Lee KH..  (1996)  Identification of ent-16 beta, 17-dihydroxykauran-19-oic acid as an anti-HIV principle and isolation of the new diterpenoids annosquamosins A and B from Annona squamosa.,  59  (6): [PMID:8786370] [10.1021/np960416j]
3. Chang FR, Yang PY, Lin JY, Lee KH, Wu YC..  (1998)  Bioactive kaurane diterpenoids from Annona glabra.,  61  (4): [PMID:9584397] [10.1021/np970497z]
4. Han L, Huang X, Sattler I, Dahse HM, Fu H, Lin W, Grabley S..  (2004)  New diterpenoids from the marine mangrove Bruguiera gymnorrhiza.,  67  (9): [PMID:15387677] [10.1021/np040062t]
5. Deng X, Shen Y, Yang J, He J, Zhao Y, Peng LY, Leng Y, Zhao QS..  (2013)  Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.,  65  [PMID:23747808] [10.1016/j.ejmech.2013.05.010]

Source